1. AB0201 Association between baseline calprotectin serum levels and response to biological therapy in patients with rheumatoid arthritis. (12th June 2018) Authors: Martinez-Feito, A.; Plasencia, C.; Jochems, A.; Navarro-Compan, V.; Pascual-Salcedo, D.; Hernández-Breijo, B.; Nozal, P.; Peiteado, D.; Villalba, A.; Mezcua, A.; Balsa, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0305 Influence of Drug Levels during The First Anti-Tnf Therapy on The Clinical Response To A Second Biologic in Rheumatoid Arthritis Patients. (15th July 2016) Authors: Plasencia-Rodriguez, C.; Pascual-Salcedo, M.D.; Bonilla, G.; Navarro-Compán, V.; Martinez-Feito, A.; Diego, C.; Villalba, A.; Peiteado, D.; Nuño, L.; Martin-Mola, E.; Balsa, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0418 The effect of concomitant methotrexate on serum tnf inhibitors levels and clinical response in patients with rheumatoid arthritis is dose dependent and greater than other dmards. (12th June 2018) Authors: Martinez-Feito, A.; Plasencia, C.; Navarro-Compan, V.; Hernández-Breijo, B.; Gonzalez, M.A.; Monjo, I.; Nuño, L.; Nozal, P.; Pascual-Salcedo, D.; Balsa, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0102 Reduction of antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with previous failure to infliximab or adalimumab. (12th June 2018) Authors: Martinez-Feito, A.; Plasencia, C.; Navarro-Compan, V.; Hernández-Breijo, B.; Pascual-Salcedo, D.; Nozal, P.; Diego, C.; Monjo, I.; Nuño, L.; Balsa, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0084 Anti-carbamylated protein antibodies as potential biomarkers of disease activity in early arthritis patients. (12th June 2018) Authors: Gonzalez, A.; Regueiro, C.; Ortiz, A.M.; Nuño, L.; Peiteado, D.; Villalba, A.; Pascual-Salcedo, D.; Martinez-Feito, A.; Balsa, A.; Gonzalez-Alvaro, I. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0112 Utility of Calprotectin Levels as a Marker of Remission in Rheumatoid Arthritis. (9th June 2015) Authors: Garcia-Carazo, S.; de Miguel, E.; Martinez-Feito, A.; Pascual-Salcedo, D.; Arribas-Arribas, M.; Jermann, T.; Diaz, M.; Martin-Mola, E.; Balsa, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗